Generex Receives Funding Commitment
08 avr. 2010 10h43 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., April 8, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex Launches $250,000,000 Lawsuit Against TheStreet.com and Feuerstein
06 avr. 2010 11h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., April 6, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex Announces Expansion Plan for the U.S. FDA Expanded Access Treatment IND Program for Generex Oral-lyn(TM) in the United States
29 mars 2010 09h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., March 29, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex Biotechnology Demands Retraction of False and Misleading Article
23 mars 2010 08h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., March 23, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) has demanded a retraction of and apologies for the inaccuracies in an online...
Generex Oral-lyn(TM) Presentation at CODHy Congress
16 mars 2010 09h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., March 16, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex Receives Positive Responses From Independent Physicians and Nurse Practitioners in Recent Focus Groups Conducted in the United States for Generex Oral-lyn(TM)
11 mars 2010 09h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., March 11, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex Establishes Key Strategic Relationships for the Development of a Distribution Network for Generex Oral-lyn(R) Under the FDA's Expanded Access Treatment IND Program
04 mars 2010 09h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., March 4, 2010 (GLOBE NEWSWIRE) -- In September of 2009, Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through...
Generex Subsidiary Antigen Express Receives Patent in China for Its Ii-Key Peptide Vaccine Technology
02 mars 2010 09h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., March 2, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) today announced that it has received notice of issuance of a patent in respect of...
Generex Announces Participation in 2010 Arab Health Congress
25 janv. 2010 09h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., Jan. 25, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex Biotechnology Highlights OTC Product Line at The Vitamin, Diet & Sports Nutrition Efficient Program Planning Session
20 janv. 2010 10h03 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., Jan. 20, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...